Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models

Our findings demonstrate that peptide-loaded nanoparticles preferentially deliver disease-relevant peptides to LSECs, thereby inducing antigen-specific immune tolerance. This versatile clinical-stage nanoparticle platform holds promise for clinical application across multiple autoimmune diseases.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-03-17
DOI
https://doi.org/10.3389/fimmu.2025.1542380
Citations
3
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
5.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models

Reinaldo Digigow, Disha Mungalpara, Sabine Fleischer, Isabelle Serr et al.
3 citations
Frontiers in Immunology
Diabetes and associated disorders
5.45
article

Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models

Reinaldo Digigow, Disha Mungalpara, Sabine Fleischer, Isabelle Serr, Cornelia Gottwick, Dikran Sarko, Agata Widera, A. Vocaturo, Muhammad Alsamman, Daria Krzikalla, Marco Fanzutti, Christian Schröter, Johannes Herkel, Carolin Daniel, Muharrem Şeleci, Antonella Carambia, Markus Heine, Alexey Surnov, Lázaro José Batista Da Silva Mesquita, Johannes Pohlner, Shu-Hung Wang, Cristina de Min, Barbara Metzler, Miriam Zahlten
article en
3 citations

Abstract

Our findings demonstrate that peptide-loaded nanoparticles preferentially deliver disease-relevant peptides to LSECs, thereby inducing antigen-specific immune tolerance. This versatile clinical-stage nanoparticle platform holds promise for clinical application across multiple autoimmune diseases.

Frontiers in ImmunologyVol. 16
Universität Hamburg (DE), University Medical Center Hamburg-Eppendorf (DE), Deutsches Diabetes-Zentrum e.V. (DE), German Center for Diabetes Research (DE), Isarna Therapeutics (Germany) (DE), Heinrich Heine University Düsseldorf (DE), Ludwig-Maximilians-Universität München (DE)
Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Good health and well-being
Openalex Percentile: Top 5%
Diabetes and associated disorders
5.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.